Metals One (AIM:MET1) is consolidating its South African gold strategy, with a deal that would lift its stake in Lions Bay Capital to 54.3%. The transaction implies a 237% unrealised gain on its investments so far.

EnergyPathways (AIM:EPP) says the next twelve months are critical for its MESH energy storage project, with a value prize running into the billions. The company's targeting a final investment decision and commercial operation by 2031.

Zephyr Energy (AIM:ZPHR) is pushing its Paradox Basin project towards first commercial production after strong drilling results in Utah. Revenue fell last year, but the company says more newsflow is coming soon.

Sunda Energy (AIM:SNDA) says it won't need to draw further convertible debt for its New Zealand acquisition, helped by stronger oil prices. Completion is now expected around September.

Poolbeg Pharma (AIM:POLB) has been granted a South African patent for its lead drug candidate, POLB 001, covering severe flu and cytokine storm prevention. The patent runs until 2038.

Futura Medical (AIM:FUM) says its experimental treatment for female sexual problems beat placebo in trials, with most women reporting improved arousal and lubrication. A pivotal study is expected to begin by the end of the year.

Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.